The Department of Health (DoH) is now evaluating the specific indications on the use of the AstraZeneca AZD1222 Covid-19 vaccine after the Food and Drug Administration (FDA) has recommended its approval for use again in adults below 60 years old.
This comes amid cases of a possible link of blood clots first reported by the European Medicines Agency, which was the basis for the temporary suspension on the use of the vaccine.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.